News
June 9, 2025: Two Indian men pleaded guilty to smuggling counterfeit cancer medicine into the U.S.
The Jha brothers admitted selling counterfeit Keytruda and other prescription drugs to undercover agents.
[...]DRAFT: Best practices for drug safety for online pharmacy to pharmacy to pharmacy marketplaces
PSM is soliciting feedback on draft best practices until June 20th. Please review the guidelines and send your thoughts to editors@safemedicines.org.
[...]June 2, 2025: FDA continues to protect Americans from unapproved and contaminated medicine
The FDA warned companies over the sale of an unapproved medical device and contaminated eye medicines, and disbarred a Texan who sold illegally imported pharmaceuticals.
[...]FDA Alert: Nationwide recall of Unavy and Umovy supplements for undeclared drug ingredients
The FDA has announced a voluntary nationwide recall of two dietary supplements sold exclusively online by www.umary-usa.com. Lab testing revealed that Unavy Ácido HIALURÓNICO and Umovy Ácido HIALURÓNICO contain undeclared active pharmaceutical ingredients: diclofenac, dexamethasone, and omeprazole.
[...]The End of GLP-1 Compounding
Federally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.
[...]May 27, 2025: Global effort to disrupt darknet marketplaces yields 4,400 pounds of illicit drugs
Operation RapTor led to 270 arrests and the seizure of more than $200 million in currency and digital assets.
[...]Empower Pharmacy’s no good, very bad week
Articles in Endpoints News and the Houston Chronicle raise questions about the regulatory process for 503B compounding facilities.
[...]May 19, 2025: Investigations raise questions about product safety at a Texas compounding company
Exposes in the Houston Chronicle and Endpoints News examined Empower Pharmacy’s safety record. A grand jury indicted a Chinese company and three of its employees for pill press and counterfeit die mold sales.
[...]May 12, 2025: FDA will expand unannounced foreign facility inspections, it says
The FDA wants to ensure that domestic and foreign companies receive the same level of regulatory oversight.
Catch up on research PSM released about medicines imported from unregistered sources.
[...]Prescription Drug Freight Fraud Report, May 2025
What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.
[...]